Shc3 affects human high-grade astrocytomas survival

Lorenzo Magrassi, Luciano Conti, Andrea Lanterna, Chiara Zuccato, Marco Marchionni, Pamela Cassini, Cesare Arienta, Elena Cattaneo

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

A selective switch from expression of Shc1 gene to Shc3 occurs with maturation of neuronal precursors into postmitotic neurons. Previous studies showed that in the embryo, Shc1 is maximally expressed in dividing CNS stem cells while it is silenced in mature neurons, where it is replaced by Shc3. Under normal conditions Shc3 is never expressed by glial cells. We now show that in human astrocytomas and glioblastomas, the normal pattern of expression of Shc1/Shc3 is totally subverted, both proteins being present at the same time and in the same cells. Our data indicate that Shc3 is maximally expressed, together with Shc1, in glioblastoma, a highly proliferative tumor with little, if any, indication of neuronal differentiation. In primary cultures of glioblastoma, tumor cells maintain Shc1 expression but downregulate Shc3. Analysis of the phosphorylation status of Shc3 in human glioblastoma tumor samples in vivo indicates that it is tyrosine phosphorylated. Finally, we found that the expression of truncated variants of Shc3 with dominant-negative effects in human high-grade glioma cells that maintain Shc3 expression in vitro leads to a decreased Akt posphorylation and increased apoptosis, thus resulting in impaired survival of the transfected cells. These data suggest that She molecules play an important role in glioblastoma cell growth and survival.

Original languageEnglish
Pages (from-to)5198-5206
Number of pages9
JournalOncogene
Volume24
Issue number33
DOIs
Publication statusPublished - Aug 4 2005

Fingerprint

Astrocytoma
Glioblastoma
Survival
Cell Survival
Neurons
Neoplasms
Glioma
Neuroglia
Tyrosine
Stem Cells
Down-Regulation
Embryonic Structures
Phosphorylation
Apoptosis
Gene Expression
Growth
Proteins

Keywords

  • Brain tumors
  • Gliomas
  • Growth control
  • Neuro-oncology
  • Shc
  • Signal transduction

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Magrassi, L., Conti, L., Lanterna, A., Zuccato, C., Marchionni, M., Cassini, P., ... Cattaneo, E. (2005). Shc3 affects human high-grade astrocytomas survival. Oncogene, 24(33), 5198-5206. https://doi.org/10.1038/sj.onc.1208708

Shc3 affects human high-grade astrocytomas survival. / Magrassi, Lorenzo; Conti, Luciano; Lanterna, Andrea; Zuccato, Chiara; Marchionni, Marco; Cassini, Pamela; Arienta, Cesare; Cattaneo, Elena.

In: Oncogene, Vol. 24, No. 33, 04.08.2005, p. 5198-5206.

Research output: Contribution to journalArticle

Magrassi, L, Conti, L, Lanterna, A, Zuccato, C, Marchionni, M, Cassini, P, Arienta, C & Cattaneo, E 2005, 'Shc3 affects human high-grade astrocytomas survival', Oncogene, vol. 24, no. 33, pp. 5198-5206. https://doi.org/10.1038/sj.onc.1208708
Magrassi L, Conti L, Lanterna A, Zuccato C, Marchionni M, Cassini P et al. Shc3 affects human high-grade astrocytomas survival. Oncogene. 2005 Aug 4;24(33):5198-5206. https://doi.org/10.1038/sj.onc.1208708
Magrassi, Lorenzo ; Conti, Luciano ; Lanterna, Andrea ; Zuccato, Chiara ; Marchionni, Marco ; Cassini, Pamela ; Arienta, Cesare ; Cattaneo, Elena. / Shc3 affects human high-grade astrocytomas survival. In: Oncogene. 2005 ; Vol. 24, No. 33. pp. 5198-5206.
@article{476f625223ea44208a180bcb2546c901,
title = "Shc3 affects human high-grade astrocytomas survival",
abstract = "A selective switch from expression of Shc1 gene to Shc3 occurs with maturation of neuronal precursors into postmitotic neurons. Previous studies showed that in the embryo, Shc1 is maximally expressed in dividing CNS stem cells while it is silenced in mature neurons, where it is replaced by Shc3. Under normal conditions Shc3 is never expressed by glial cells. We now show that in human astrocytomas and glioblastomas, the normal pattern of expression of Shc1/Shc3 is totally subverted, both proteins being present at the same time and in the same cells. Our data indicate that Shc3 is maximally expressed, together with Shc1, in glioblastoma, a highly proliferative tumor with little, if any, indication of neuronal differentiation. In primary cultures of glioblastoma, tumor cells maintain Shc1 expression but downregulate Shc3. Analysis of the phosphorylation status of Shc3 in human glioblastoma tumor samples in vivo indicates that it is tyrosine phosphorylated. Finally, we found that the expression of truncated variants of Shc3 with dominant-negative effects in human high-grade glioma cells that maintain Shc3 expression in vitro leads to a decreased Akt posphorylation and increased apoptosis, thus resulting in impaired survival of the transfected cells. These data suggest that She molecules play an important role in glioblastoma cell growth and survival.",
keywords = "Brain tumors, Gliomas, Growth control, Neuro-oncology, Shc, Signal transduction",
author = "Lorenzo Magrassi and Luciano Conti and Andrea Lanterna and Chiara Zuccato and Marco Marchionni and Pamela Cassini and Cesare Arienta and Elena Cattaneo",
year = "2005",
month = "8",
day = "4",
doi = "10.1038/sj.onc.1208708",
language = "English",
volume = "24",
pages = "5198--5206",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "33",

}

TY - JOUR

T1 - Shc3 affects human high-grade astrocytomas survival

AU - Magrassi, Lorenzo

AU - Conti, Luciano

AU - Lanterna, Andrea

AU - Zuccato, Chiara

AU - Marchionni, Marco

AU - Cassini, Pamela

AU - Arienta, Cesare

AU - Cattaneo, Elena

PY - 2005/8/4

Y1 - 2005/8/4

N2 - A selective switch from expression of Shc1 gene to Shc3 occurs with maturation of neuronal precursors into postmitotic neurons. Previous studies showed that in the embryo, Shc1 is maximally expressed in dividing CNS stem cells while it is silenced in mature neurons, where it is replaced by Shc3. Under normal conditions Shc3 is never expressed by glial cells. We now show that in human astrocytomas and glioblastomas, the normal pattern of expression of Shc1/Shc3 is totally subverted, both proteins being present at the same time and in the same cells. Our data indicate that Shc3 is maximally expressed, together with Shc1, in glioblastoma, a highly proliferative tumor with little, if any, indication of neuronal differentiation. In primary cultures of glioblastoma, tumor cells maintain Shc1 expression but downregulate Shc3. Analysis of the phosphorylation status of Shc3 in human glioblastoma tumor samples in vivo indicates that it is tyrosine phosphorylated. Finally, we found that the expression of truncated variants of Shc3 with dominant-negative effects in human high-grade glioma cells that maintain Shc3 expression in vitro leads to a decreased Akt posphorylation and increased apoptosis, thus resulting in impaired survival of the transfected cells. These data suggest that She molecules play an important role in glioblastoma cell growth and survival.

AB - A selective switch from expression of Shc1 gene to Shc3 occurs with maturation of neuronal precursors into postmitotic neurons. Previous studies showed that in the embryo, Shc1 is maximally expressed in dividing CNS stem cells while it is silenced in mature neurons, where it is replaced by Shc3. Under normal conditions Shc3 is never expressed by glial cells. We now show that in human astrocytomas and glioblastomas, the normal pattern of expression of Shc1/Shc3 is totally subverted, both proteins being present at the same time and in the same cells. Our data indicate that Shc3 is maximally expressed, together with Shc1, in glioblastoma, a highly proliferative tumor with little, if any, indication of neuronal differentiation. In primary cultures of glioblastoma, tumor cells maintain Shc1 expression but downregulate Shc3. Analysis of the phosphorylation status of Shc3 in human glioblastoma tumor samples in vivo indicates that it is tyrosine phosphorylated. Finally, we found that the expression of truncated variants of Shc3 with dominant-negative effects in human high-grade glioma cells that maintain Shc3 expression in vitro leads to a decreased Akt posphorylation and increased apoptosis, thus resulting in impaired survival of the transfected cells. These data suggest that She molecules play an important role in glioblastoma cell growth and survival.

KW - Brain tumors

KW - Gliomas

KW - Growth control

KW - Neuro-oncology

KW - Shc

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=23444457770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23444457770&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1208708

DO - 10.1038/sj.onc.1208708

M3 - Article

C2 - 15870690

AN - SCOPUS:23444457770

VL - 24

SP - 5198

EP - 5206

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 33

ER -